SREBF1 and fatty liver disease: Phosphorylated AMPK can phosphorylate the Ser372 residue of SREBP-1c to inhibit the expression of SREBP-1c, reducing fatty acid synthesis and lipid accumulation, and improving hepatic steatosis [52].